telmesteine has been researched along with thiazolidines in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gianotti, A | 1 |
| Kim, DH; Lee, J; Rhee, SW; Son, J | 1 |
| Abramovits, W; Boguniewicz, M | 1 |
| Inoue, M; Ishida, S; Izumi-Nagai, K; Koto, T; Nagai, N; Oike, Y; Ozawa, Y; Satofuka, S; Tsubota, K; Umezawa, K; Yamashiro, K | 1 |
| Innocenti, M; Menter, A; Veraldi, S | 1 |
3 trial(s) available for telmesteine and thiazolidines
| Article | Year |
|---|---|
[Telemestein and variations in blood concentrations of lipoprotein A].
Topics: Adult; Female; Humans; Hyperlipoproteinemias; Infant, Newborn; Lipoprotein(a); Male; Middle Aged; Nephelometry and Turbidimetry; Thiazoles; Thiazolidines; Time Factors | 1994 |
A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colorado; Dermatitis, Atopic; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Glycyrrhetinic Acid; Humans; Hyaluronic Acid; Male; Middle Aged; Plant Extracts; Severity of Illness Index; Texas; Thiazoles; Thiazolidines; Treatment Outcome; Vitis | 2006 |
Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial.
Topics: Administration, Topical; Adult; Aged; Alkanes; Allantoin; Dermatitis, Seborrheic; Dermatologic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Humans; Male; Middle Aged; Monocyclic Sesquiterpenes; Ointments; Pilot Projects; Pyridones; Quality of Life; Sesquiterpenes; Severity of Illness Index; Thiazolidines; Treatment Outcome; Vitamin E | 2008 |
2 other study(ies) available for telmesteine and thiazolidines
| Article | Year |
|---|---|
Absorption, distribution, metabolism and excretion of telmesteine, a mucolitic agent, in rat.
Topics: Absorption; Administration, Oral; Animals; Bile; Biological Availability; Dose-Response Relationship, Drug; Expectorants; Female; Injections, Intravenous; Liver; Male; Organ Specificity; Rats; Rats, Sprague-Dawley; Sex Factors; Thiazoles; Thiazolidines; Tissue Distribution | 2003 |
Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzamides; Blotting, Western; Cell Adhesion; Chemokine CCL2; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Imidazoles; Intercellular Adhesion Molecule-1; Leukocytes; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Pyridines; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Retinitis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Thiazolidines; Valine; Valsartan; Vascular Endothelial Growth Factor A | 2007 |